Latest News about NASDAQ:CNTX
Recent news which mentions NASDAQ:CNTX
Tickers
CNTX
From InvestorPlace
Tickers
CNTX
From InvestorPlace
Context Therapeutics CEO Marty Lehr notes progress towards the clinic with CTIM-76 in 2Q update
August 10, 2023
Tickers
CNTX
Tags
NASDAQ:CNTX
From News Direct
Context Therapeutics shares #ASCO23 data on CLDN-6 targeted treatments and CTIM-76 update
June 13, 2023
Tags
NASDAQ:CNTX
From News Direct
Context Therapeutics CTIM-76 bispecific antibody preclinical data presented at AACR Annual Meeting
April 24, 2023
Tags
NASDAQ:CNTX
From News Direct
Tags
NASDAQ:CNTX
From News Direct
Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers
December 06, 2022
Tags
NASDAQ:CNTX
From News Direct
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>